Accelerate Diagnostics, Inc.
AXDX
$0.65
-$0.045-6.48%
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -5.34% | -0.37% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -5.34% | -0.37% | |||
| Cost of Revenue | 11.70% | -8.27% | |||
| Gross Profit | -47.55% | 26.63% | |||
| SG&A Expenses | -18.26% | 4.78% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -7.29% | 0.01% | |||
| Operating Income | 7.96% | -0.14% | |||
| Income Before Tax | 34.05% | -26.33% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 34.50% | -26.33% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 34.50% | -26.33% | |||
| EBIT | 7.96% | -0.14% | |||
| EBITDA | 7.96% | -0.14% | |||
| EPS Basic | 35.26% | -16.91% | |||
| Normalized Basic EPS | -29.44% | 14.11% | |||
| EPS Diluted | 35.26% | -16.91% | |||
| Normalized Diluted EPS | -29.44% | 14.11% | |||
| Average Basic Shares Outstanding | 1.17% | 8.05% | |||
| Average Diluted Shares Outstanding | 1.17% | 8.05% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
